top of page

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

© Hairuhusiwi kukopi bila kibali cha ULYCLINIC

ULY CLINIC

28 Februari 2026, 14:16:03

Image-empty-state.png
Image-empty-state.png
Image-empty-state.png
Image-empty-state.png

Urolithiasis

23 Novemba 2020, 12:29:46

Urolithiasis refers to the formation of calculi (stones) within the urinary tract, including the renal calyces, renal pelvis, ureters, or urinary bladder, resulting from urine that becomes supersaturated with stone-forming salts.


Stone formation occurs when crystallization exceeds the natural inhibitory mechanisms of urine, leading to aggregation and retention of mineral deposits. Urolithiasis is a common urological condition and an important cause of acute flank pain and urinary obstruction.


Epidemiology

  • Lifetime risk: 10–15% globally

  • More common in males than females

  • Peak age: 20–50 years

  • High recurrence rate (≈50% within 5–10 years)


Types of Urinary Stones

  1. Calcium oxalate stones (most common)

  2. Calcium phosphate stones

  3. Uric acid stones

  4. Struvite stones (infection-related)

  5. Cystine stones (genetic disorders)


Risk Factors


Metabolic Factors

  • Hypercalciuria

  • Hyperoxaluria

  • Hyperuricaemia

  • Low urinary citrate

  • Dehydration


Dietary Factors

  • Low fluid intake

  • High salt intake

  • Excess animal protein

  • High oxalate diet

  • Excess sugar intake


Medical Conditions

  • Recurrent urinary tract infections

  • Gout

  • Obesity

  • Hyperparathyroidism

  • Chronic kidney disease

  • Malabsorption syndromes


Environmental Factors

  • Hot climate

  • Excessive sweating

  • Sedentary lifestyle


Genetic Factors

  • Family history of stone disease

  • Cystinuria


Pathophysiology

Stone formation involves:

  1. Urinary supersaturation

  2. Crystal nucleation

  3. Crystal growth

  4. Aggregation

  5. Retention within urinary tract


Urinary obstruction caused by stones leads to:

  • Increased intraluminal pressure

  • Ureteric spasm

  • Renal capsule distension → severe colicky pain


Signs and Symptoms


Classical Presentation

  • Sudden onset severe flank pain (renal colic)

  • Restlessness (patient unable to remain still)

  • Pain radiating to groin, scrotum, or labium

  • Nausea and vomiting


Urinary Symptoms

  • Haematuria (microscopic or gross)

  • Dysuria

  • Urinary frequency or urgency


Complicated Disease

  • Fever and chills (infection)

  • Reduced urine output

  • Signs of sepsis

  • Acute kidney injury

Diagnostic Criteria

Diagnosis is based on clinical features supported by imaging and laboratory findings:

  • Sudden acute flank colic

  • Nausea and vomiting

  • Haematuria

  • Referred genital pain

  • Urinalysis showing infection or microscopic haematuria

  • Ultrasound showing acoustic shadow or obstructive uropathy (hydronephrosis/hydroureter)

  • Plain abdominal X-ray detecting radio-opaque calculi

  • CT urography or intravenous urogram confirming urinary tract lithiasis


Investigations


Laboratory Tests

  • Urinalysis

  • Urine culture

  • Serum creatinine

  • Blood urea nitrogen

  • Electrolytes

  • Serum calcium

  • Serum uric acid

  • Full blood count


Imaging Studies


First-line

  • Ultrasound abdomen and pelvis


Gold Standard

  • Non-contrast CT scan (CT KUB)


Additional Imaging

  • Plain X-ray KUB

  • Intravenous urography (IVU)


Management


Treatment Objectives

  • Pain control

  • Facilitate stone passage

  • Treat infection

  • Relieve obstruction

  • Prevent recurrence


Pharmacological Management


Analgesia

Ibuprofen 400 mg PO 8 hourly for 3 days

OR

Tramadol injection 100 mg stat, thenTramadol 50 mg PO 8 hourly

NSAIDs are preferred as they reduce ureteric spasm and inflammation.


Medical Expulsive Therapy

For distal ureteric stones <7 mm:

Tamsulosin 0.4 mg PO once daily for 4 weeks

Enhances spontaneous stone passage by relaxing ureteric smooth muscle.


Antibiotics

Indicated when infection is present according to culture results.

Obstruction + infection = urological emergency


Non-Pharmacological Management


Hydration

  • Fluid intake: 2.5–3 litres/day

  • Target urine output: >2.5 litres/day


Dietary Measures

  • Balanced diet rich in vegetables and fibre

  • Normal calcium intake: 1–1.2 g/day

  • Reduce sodium intake: 4–5 g/day

  • Limit animal protein: 0.8–1.0 g/kg/day

  • Reduce oxalate-rich foods when indicated


Indications for Surgical


Intervention

Referral to specialized urology centres is required when:

  • Stone >7–10 mm

  • Persistent severe pain

  • Obstruction

  • Renal impairment

  • Failed conservative therapy

  • Recurrent infections

  • Single functioning kidney


Emergency Management

In obstructive uropathy with infection:

Immediate decompression required via:

  • Percutaneous nephrostomyOR

  • Ureteric Double-J (DJ) stenting


Definitive Surgical Options

  • Extracorporeal Shock Wave Lithotripsy (ESWL)

  • Ureteroscopy with laser lithotripsy

  • Percutaneous nephrolithotomy (PCNL)

  • Open or laparoscopic surgery (rare)


Complications

  • Hydronephrosis

  • Recurrent urinary tract infection

  • Pyelonephritis

  • Urosepsis

  • Renal failure

  • Stone recurrence


Prevention


Lifestyle Prevention

  • Maintain high fluid intake

  • Regular physical activity

  • Weight control


Dietary Prevention

  • Reduce salt intake

  • Moderate animal protein consumption

  • Adequate dietary calcium

  • Avoid excessive oxalate foods


Medical Prevention

Based on metabolic evaluation:

  • Thiazide diuretics

  • Potassium citrate

  • Allopurinol (uric acid stones)


Patient Education

  • Early medical consultation for flank pain

  • Maintain hydration daily

  • Complete treatment even after pain resolution

  • Regular follow-up for recurrent stones

  • Dietary modification reduces recurrence risk


References

  1. European Association of Urology. EAU Guidelines on Urolithiasis. 2024.

  2. Türk C, et al. EAU Guidelines on Urolithiasis. Eur Urol. 2023.

  3. American Urological Association. Medical Management of Kidney Stones Guideline. AUA; 2022.

  4. Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2021.

  5. National Institute for Health and Care Excellence (NICE). Renal and ureteric stones management. London; 2023.

  6. Ministry of Health. Standard Treatment Guidelines (STG). 2023 Edition.

  7. Pearle MS, et al. Medical management of kidney stones. J Urol. 2019.


Imeandikwa:

bottom of page